Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05804448
Other study ID # 533/2022 P
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 18, 2023
Est. completion date April 20, 2025

Study information

Verified date April 2023
Source B.P. Koirala Institute of Health Sciences
Contact Asish Subedi, MD
Phone 9842040604
Email ashish.subedi@bpkihs.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to examine the effects of altitude (high altitude versus low altitude) on incidence and severity of postural puncture headache (PDPH) following spinal anaesthesia for caesarean delivery. The investigators hypothesized that the risk of PDPH would be higher in highlander parturients than in lowlander parturients.


Description:

This will be a prospective cohort study conducted in two different altitudes in Nepal. The high-altitude site is in Jumla, approximately 2514 m above the sea level, and a low altitude city is Dharan, located at 350 m from sea level. The investigators will screen the eligible participant admitted to the in-patient obstetric unit. The investigator will also record patient baseline characteristics, preoperative anxiety, antenatal depression, presence of chronic pain conditions or preexisting headache. Spinal anaesthesia will be administered in the sitting position at the L3-L4 or L4-L5 interspace using a 25-G pencil point spinal needle (PencanĀ® 25-gauge). The diagnosis of post-dural puncture headache will be based on the international headache society ICDH-3 criteria


Recruitment information / eligibility

Status Recruiting
Enrollment 292
Est. completion date April 20, 2025
Est. primary completion date January 20, 2025
Accepts healthy volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Parturient, aged more than or equal to 18 years - American society of Anesthesiologist 2 and 3 - Scheduled for elective and non-elective (category 2 & 3) caesarean delivery with spinal anesthesia - Native to their resident altitude i.e., those born, raised, and have continuously lived at the same altitude, at least for the past 1 year. Exclusion Criteria: - Hypertensive disorder - Cerebrovascular disease - Mental disorder (schizophrenia and other psychotic disorders) - Known fetal anomalies - Contraindication to spinal anaesthesia. - Those requiring general anaesthesia for delivery due to failed spinal anesthesia - Major post-delivery complications (severe haemorrhage, sepsis, or ICU admission) - Those who migrate from their resident altitude (either low to high or vice versa) within 7 days post-delivery will also be excluded.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Nepal BP Koirala Institute of Health Sciences (BPKIHS) Dharan Bazar Koshi
Nepal Karnali Academy of Health Sciences Jumla Karnali

Sponsors (2)

Lead Sponsor Collaborator
B.P. Koirala Institute of Health Sciences Karnali Academy of Health Sciences

Country where clinical trial is conducted

Nepal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with postdural puncture headache The diagnosis of post-dural puncture headache will be based on the international headache society ICDH-3 criteria: a headache that occurs within 5 days of a dural puncture, is located in the occipital and/or frontal areas, worsens within 15 min of sitting or standing and alleviates within 15 min after lying down, associated with at least one of the following features: neck stiffness, nausea, vomiting, photophobia, and tinnitus, and resolves either spontaneously within 1 week or within 48 h after effective treatment. up to 7 days after spinal anesthesia
Secondary Number of patients with severity of postdural puncture headache using a numeric rating scale (NRS), with 0= NO pain 10=worst imaginable pain, and classified as none (NRS=0), mild (1-3), moderate (4-6), and severe (7-10) up to 7 days after spinal anesthesia
Secondary Pain assessed by PROMIS pain interference scale 6-item PROMIS Pain Interference short form scale will be used to assess the self-reported consequences of PDPH on social, cognitive, physical, and recreational activities. Respondents will be asked to rate the interference of pain in each activity listed using a 1 to 5 scale, where 1 = Not at all. 2 = A little bit, 3 = Somewhat, 4 = Quite a bit, and 5 = Very much 7 days after occurrence of postdural puncture headache
Secondary Number of patients with non-postdural puncture headache Headache that is not related to posture up to 7 days after spinal anesthesia
Secondary Number of patients who received treatment for postdural puncture headache paracetamol, NSAID's, caffeine, opioids, glossopharyngeal nerve block, sphenopalatine ganglion block and epidural blood patch up to 1 month after occurrence of PDPH
Secondary Number of patient with chronic headache Headache that is persistent after postdural puncture headache or after non-postdural puncture headache At 1 and 3 months after occurrence of headache following spinal anesthesia
Secondary Number of patients with chronic backache Presence of backache after spinal anesthesia At 1 and 3 months after spinal anesthesia
Secondary Number of patients with chronic post surgical pain Pain that develops or increases in intensity after cesarean section and persists at least 3 months after the surgery. The pain has to be localised to the surgical field or area of injury. Other causes of pain such as pre-existing pain conditions or infections, or malignancy etc. have to be excluded. 3 month after caesarean section
See also
  Status Clinical Trial Phase
Completed NCT04091321 - Association Between Chronic Headache and Back Pain With Childbirth
Recruiting NCT05202574 - Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients Undergoing Caesarean Section Phase 2
Terminated NCT02813655 - Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) Phase 2
Completed NCT02522013 - Aminophylline for Patients With Post-Dural Puncture Headache Phase 3
Recruiting NCT06444737 - Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia N/A
Completed NCT05301387 - The Effect of Ganglion Sphenopalatine Block (GSP-block) Follow-Up
Recruiting NCT05637645 - Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section N/A
Recruiting NCT05116930 - Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture Phase 2
Terminated NCT03430531 - Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache Phase 2
Completed NCT04401878 - SGB in Management of Patients With PDPH Using TCD N/A
Completed NCT04327726 - Effectiveness of Nebulized Dexmedetomidine for Treatment of Obstetric Post-Dural Puncture Headache N/A
Completed NCT03475784 - Two Fluid Strategies for Prevention of Post-dural Puncture Headache Phase 3
Not yet recruiting NCT06272916 - Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section.
Terminated NCT02827058 - The Influence of Needle Diameter on Post Dural Puncture Headache N/A
Completed NCT05262933 - Effects of Preoperative Coffee Consumption in Cesarean Sections Under Spinal Anesthesia
Completed NCT04793490 - Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients N/A
Recruiting NCT05888324 - Factors Associated With the Onset of Chronic Headaches in Patients Who Received a Blood Patch in Post Partum
Completed NCT00370604 - Effect of Small Versus Large Epidural Needles on Postdural Puncture Headache Study N/A
Completed NCT04844229 - Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache N/A
Withdrawn NCT03560349 - RCT of SPG Blocks for Post-dural Headache Phase 2